Valentijn Vergote

LC-UV/MS quality analytics of paediatric artemether formulations

Kirsten Vandercruyssen (UGent) , Matthias D'Hondt, Valentijn Vergote (UGent) , Herwig Jansen, Christian Paul G. Burvenich (UGent) and Bart De Spiegeleer (UGent)

(2014) JOURNAL OF PHARMACEUTICAL ANALYSIS. 4(1). p.37-52

Add to list

Journal Article
A1
open access

In vitro metabolic stability of iodinated obestatin peptides

Bart De Spiegeleer (UGent) , Sylvia Van Dorpe (UGent) , Valentijn Vergote (UGent) , Evelien Wynendaele (UGent) , Ewald Pauwels (UGent) , Christophe Van De Wiele (UGent) , Pablo Garcia-Solis and Juan Carlos Solis-Sainz

(2012) PEPTIDES. 33(2). p.272-278

Add to list

Conference Paper
C3
open access

HPLC-MS characterisation of chelate modified somatropin

Evelien Wynendaele (UGent) , Ewald Pauwels (UGent) , Sylvia Van Dorpe (UGent) , Valentijn Vergote (UGent) , Christophe Van De Wiele (UGent) and Bart De Spiegeleer (UGent)

(2010) Vlaams Jongerencongres van de Chemie, 10e, Abstracts.

Add to list

Hydrophilic interaction LC of peptides: columns comparison and clustering

Sylvia Van Dorpe (UGent) , Valentijn Vergote (UGent) , Adel Pezeshki (UGent) , Christian Paul G. Burvenich (UGent) , Kathelijne Peremans (UGent) and Bart De Spiegeleer (UGent)

(2010) JOURNAL OF SEPARATION SCIENCE. 33(6-7). p.728-739

Add to list

PhD Thesis

Functional quality analytics of peptide drugs: the obestatin case

Valentijn Vergote (UGent)

(2010)

Add to list

Metabolic fate of lactoferricin based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability

Johan Svenson, Valentijn Vergote (UGent) , Rasmus Karsted, Christian Paul G. Burvenich (UGent) , John Svendsen and Bart De Spiegeleer (UGent)

(2010) JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 332(3). p.1032-1039

Add to list

Chemical and metabolic stability of lactoferricin-derived cationic antimicrobial tripeptides

Bart De Spiegeleer (UGent) , Valentijn Vergote (UGent) , Johan Svenson, Rasmus Karstad and Christian Paul G. Burvenich (UGent)

(2009) PBA2009USA Program and Abstract Book.

Add to list

Quality specifications for peptide drugs: a regulatory-pharmaceutical approach

Valentijn Vergote (UGent) , Christian Paul G. Burvenich (UGent) , Christophe Van De Wiele (UGent) and Bart De Spiegeleer (UGent)

(2009) Journal of Peptide Science. 15(11). p.697-710

Add to list

Development of peptide receptor binding assays: methods to avoid false negatives

Valentijn Vergote (UGent) , Sylvia Van Dorpe (UGent) , Mathieu Verbeken (UGent) , Christian Paul G. Burvenich (UGent) , Christophe Van De Wiele (UGent) , William Banks and Bart De Spiegeleer (UGent)

(2009) REGULATORY PEPTIDES. 158(1-3). p.97-102

Add to list

Central administration of obestatin fails to show inhibitory effects on food and water intake in mice

Annemie Van Dijck, Debby Van Dam, Valentijn Vergote (UGent) , Bart De Spiegeleer (UGent) , Walter Luyten, Liliane Schoofs and Peter Paul De Deyn

(2009) Regulatory Peptides. 156(1-3). p.77-82

Academic Bibliography

Valentijn Vergote

LC-UV/MS quality analytics of paediatric artemether formulations

In vitro metabolic stability of iodinated obestatin peptides

HPLC-MS characterisation of chelate modified somatropin

Hydrophilic interaction LC of peptides: columns comparison and clustering

Functional quality analytics of peptide drugs: the obestatin case

Metabolic fate of lactoferricin based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability

Chemical and metabolic stability of lactoferricin-derived cationic antimicrobial tripeptides

Quality specifications for peptide drugs: a regulatory-pharmaceutical approach

Development of peptide receptor binding assays: methods to avoid false negatives

Central administration of obestatin fails to show inhibitory effects on food and water intake in mice

Contents

Support

Contact